Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like GlaxoSmithKline Poaches New CSO From Google's Calico November 8, 2017 SanBio, Inc. Receives $20 Million Grant From For Stroke Clinical Trial July 4, 2017 BlueRock Therapeutics Sets Up HQ in Cambridge, Expands Executive Team October 25, 2017
